carvediol (carvedilol) News
New Beta Blocker Drug Reduces Heart Risks
Carvedilol, a newer member of the beta blocker family of heart drugs, saved more lives of patients with heart failure than an older drug and also cut the incidence of heart attacks and other events, European researchers report.
FDA Approves New, Once-a-Day COREG CR(TM) for the Treatment of Three Key Cardiovascular Conditions
GlaxoSmithKline (NYSE: GSK - News) and Flamel Technologies (Nasdaq: FLML - News) today announced FDA approval of once-a-day Coreg CR(TM) (carvedilol phosphate) extended-release capsules, for the treatment of three cardiovascular...
Flamel’s losses soar as it gears up for Coreg
As it prepares for the launch of GlaxoSmithKline’s beta-blocker Coreg (carvedilol) with a controlled release formulation, drug delivery company Flamel saw its bottom line, in the absence of new partners, shift deep into the red...
New Data Show COREG CR (TM) Reduced Blood Pressure In Patients With Essential Hypertension
Philadelphia - Coreg CR(TM) (carvedilol phosphate controlled-release capsules), a controlled-release beta blocker, reduced blood pressure over a full 24-hour dosing interval, according to data presented today at the American...
Taro Receives Tentative ANDA Approvals For Carvedilol Tablets
Hawthorne, N.Y.(PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. and its affiliates and subsidiaries (Nasdaq: TARO) reported today that it has received tentative approval from the U.S. Food and Drug Administration ("FDA") for...